Potential prescribing issues among older HIV-infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern?

Cora Loste José Moltó Núria Pérez-ÁlvarezJordi PuigPatricia Echeverría Anna Bonjoch Carmina R FumazBegoña LemosCarla Estany Bonaventura Clotet Sala Eugènia Negredo

Published in: British journal of clinical pharmacology (2020)

The prevalence of PPI among older HIV-infected persons gives cause for concern, as it is almost 90%. Optimization strategies, including a critical review of the treatment plan, should be implemented in clinical routine by a multidisciplinary team, in particular in patients with multiple comorbidities and polypharmacy. The STOPP/START criteria seem to detect more PPI, mainly for European populations.

Keyphrases

hiv infected
antiretroviral therapy
risk factors
human immunodeficiency virus
protein protein
primary care
palliative care
quality improvement
adverse drug
emergency department
clinical practice
human health
climate change
hepatitis c virus
genetic diversity
electronic health record
smoking cessation